skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I have an average cost base of $190 for Kinaxis. I still think it is a good company but was thinking it is maybe time to take a capital loss and move on. I was wondering if there are companies that you prefer more at current valuations and growth potential at this point in time? Or is Kinaxis at the top of the list and I should stick with it?
Read Answer Asked by James on March 12, 2021
Q: The new CEO has been in place for about 18 months now and the latest financial reports were solid. While you never "disowned" the stock it was dropped from the portfolio. Would you be a buyer of this stock now, anticipating growth in lumber in particular as well as M&A activity or is it too soon yet to judge this new exec team?

Appreciate your insight.

Paul F.
Read Answer Asked by Paul on March 12, 2021
Q: Friday morning 9:40am and XBC is down heavy based on pre-announcement of sales decline. XBC has been touted as one of 5i's top growth stocks. But things happen. In earlier question today you replied that you would have to do more work on this. How and when will this new information be passed along? How do you now rate the stock? Is this a one time incident that will be overcome or does this significantly change your view?
Read Answer Asked on March 12, 2021
Q: I would appreciate your comments of the latest acquisition, Vend.
“Vend generated revenue of approximately $34 million and GTV3 of more than $7 billion in the trailing twelve month period ending December 31st, 2020. Lightspeed will acquire Vend for total estimated consideration of approximately $350 million, satisfied by way of payment on closing of approximately $192.5 million in cash and the issuance of subordinate voting shares in the capital of Lightspeed valued at approximately $157.5 million. The deal, which is subject to customary closing conditions and post-closing working capital adjustment, is expected to close towards the end of April, subject to the receipt of applicable regulatory approvals.”
As always - many thanks.
Clayton
Read Answer Asked by Clayton on March 12, 2021
Q: One of the "highlights" from Kinaxis' recent quarter was the decline in gross profit. From what I can tell, it seems that R&D spending was significantly higher, in part to augment AI capabilities. Can you shed any light on this decrease in profit and if it was from higher R&D is that not a good use of capital and does that not bode well for the company going forward?

Appreciate your insight.

Paul F.
Read Answer Asked by Paul on March 12, 2021
Q: So working in the finance industry, when it comes to business valuation, I know private health clinics get very low multiples. If Well is continues to consolidate in a space where now one else is and provides technological efficiencies. Even if they are just able to capture the majority of market share in Canada, could the potential upside be the sky?
Read Answer Asked by James on March 11, 2021
Q: Hi 5i team,
My nephew turned 18 last year and has now 11K in his TFSA ready to invest.
What would be your suggestion (s). It can be a mix of CDN and USD stocks/ETFs.
Obviously, it would be several years before needing any of the money so some risk can be taken.
Thanks
Read Answer Asked by Marco on March 08, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!